当前位置: 首页 > 详情页

The possible mechanism for impaired angiogenesis after transient focal ischemia in type 2 diabetic GK rats: Different expressions of angiostatin and vascular endothelial growth factor

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Shandong Univ, Affiliated Qianfoshan Hosp, Dept Neurol, Jinan 250014, Shandong, Peoples R China; [2]Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [3]Shandong Med Coll, Affiliated Hosp, Linyi, Shandong, Peoples R China; [4]Shandong Univ, Affiliated Qianfoshan Hosp, Dept Neurol, 66 Jingshi Rd, Jinan 250014, Shandong, Peoples R China
出处:
ISSN:

关键词: Angiogenesis Diabetes mellitus Angiostatin Vascular endothelial growth factor MMP-9

摘要:
Background: The development of collateral vessels, which is important to prevent ischemic tissues from cell death, is impaired in patients with diabetes mellitus. The process is regulated by many positive and negative factors. The purpose of the study is to test the hypothesis that stroke patients with diabetes have angiogenesis deficiency and the possible mechanism is hyperglycemia attenuates neovascularization by downregulating proliferative properties of vascular endothelial growth factor (VEGF) and upregulating negative properties of angiostatin. Methods: Diabetes groups [Goto-Kakizaki (GK)] and respective controls (Wistar rats) underwent 1.5 h of middle cerebral artery occlusion (MCAO) and then reperfused for 24 h and 7d. Immunohistochemisty was used to describe the change of vessel density. The expression levels of VEGF and angiostatin were estimated by western blot. Results: Compared with the controls, the diabetes groups had lower vessel density, more expression of angiostatin, and lower level of VEGF. Conclusions: These results showed angiogenesis was deficient in diabetes groups after ischemical reperfusion (I/R) injury. And the possible mechanism is hyperglycemia attenuates neovascularization by downregulating proliferative properties of VEGF and upregulating of negative properties of angiostatin. (C) 2009 Elsevier Masson SAS. All rights reserved.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2009]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2023]版:
大类 | 2 区 医学
小类 | 1 区 药学 2 区 医学:研究与实验
JCR分区:
出版当年[2008]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2008版] 出版当年五年平均 出版前一年[2007版] 出版后一年[2009版]

第一作者:
第一作者机构: [1]Shandong Univ, Affiliated Qianfoshan Hosp, Dept Neurol, Jinan 250014, Shandong, Peoples R China;
通讯作者:
通讯机构: [1]Shandong Univ, Affiliated Qianfoshan Hosp, Dept Neurol, Jinan 250014, Shandong, Peoples R China; [4]Shandong Univ, Affiliated Qianfoshan Hosp, Dept Neurol, 66 Jingshi Rd, Jinan 250014, Shandong, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院